• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Deals

graphic art of a right hand signing something
Pharma

Biogen taps Alteogen for help developing 2 subQ biologics

After attracting GSK with its subcutaneous delivery tech earlier this year, South Korea’s Alteogen has snared another Big Pharma partner in Biogen.
Fraiser Kansteiner Mar 25, 2026 10:55am
Servier

Servier rounds out rare cancer offerings with $2.5B Day One buy

Mar 6, 2026 10:14am
two jiggsaw puzzles connected with drawn hands shaking on the two puzzles

CDMO Quotient extends Ipsen supply deal for rare disease drug

Mar 2, 2026 11:00am
calendar
Favicon Fierce Biotech

Protagonist prefers $400M from Takeda over rusfertide US profits

Feb 26, 2026 10:00am
more expensive
Favicon Fierce Biotech

China is no longer licensing 'bargain basement': analyst

Feb 24, 2026 5:07pm
Expensive laboratory tests

Manus Bio scores $15M from US to supply influenza drug component

Feb 19, 2026 3:35pm
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings